Vireo Growth Inc. Announces Retirement of November 2024 Convertible Note

Core Points - Vireo Growth Inc. announced the retirement of a US$10 million convertible note originally issued on November 1, 2024, and concurrently issued a new US$10 million convertible note as part of its refinancing initiatives [1] - The repayment and issuance of the convertible notes are classified as a "related party transaction" under Multilateral Instrument 61-101, exempting them from formal valuation and minority shareholder approval requirements [2] - The new convertible note was issued under exemptions from the registration requirements of the U.S. Securities Act and applicable Canadian and U.S. state securities laws [3] Company Overview - Vireo Growth Inc. was founded in 2014 as a pioneer in the medical cannabis industry, focusing on building a disciplined and execution-oriented platform while leveraging a national portfolio [4]